Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 17

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 17
---
 not less than the fair market value of common stock on the date of grant. Generally, options become exercisable over three years
from the grant date and expire five years after the date of grant. 

Milestone
Scientific recognizes compensation expenses over the requisite service period and in the case of performance-based options over the period
of the expected performance. For the three and nine months ended September 30, 2025, Milestone Scientific recognized approximately $362,000
and $691,000 of total employee compensation cost, respectively, recorded in general and administrative expenses on the statement
of operations. For the three and nine months ended September 30, 2024, Milestone Scientific recognized approximately $172,000 and $530,000 of
total employee compensation cost, respectively, recorded in general and administrative expenses on the statement of operations.

As
of September 30, 2025, there was $1.6 million of total unrecognized compensation cost related to non-vested options. Milestone
Scientific expects to recognize these costs over a weighted average period of 0.50 years.

A summary of option activity for employees under the plans and changes during the nine months ended September 30, 2025 is presented below:

 SCHEDULE
OF STOCK OPTION ACTIVITY

    Number of Options  
    Weighted Averaged Exercise Price $  
    Weighted Average Remaining Contractual Life (Years)  
    Aggregate Intrinsic Options
                                                                                Value $ 
  
    Options outstanding at January 1, 2025 
     2,951,989  
     2.29  
     4.54  
     - 
  
    Granted during 2025 
     4,000,000  
     0.48  
     9.85  
     - 
  
    Exercised during 2025 
     -  
     -  
     -  
     - 
  
    Forfeited or expired during 2025 
     (216,296) 
     1.52  
     -  
     - 
  
    Options outstanding September 30, 2025 
     6,735,693  
     1.25  
     7.53  
     - 
  
    Exercisable, September 30, 2025 
     2,735,694